We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Gene Variation Is Responsible for Dog Sizes

By Biotechdaily staff writers
Posted on 17 Apr 2007
Investigators have found that variation in one gene--IGF-1, which codes for a protein hormone called insulin-like growth factor 1, is very strongly associated with small stature across different dog breeds

In their study, scientists explored the genetic basis for size variation among dogs by comparing the DNA of various small dog breeds, including Chihuahuas, Toy Fox Terriers, and Pomeranians, to an array of larger dog breeds, including Irish Wolfhounds, Saint Bernards, and Great Danes. More...
The branch of the canine family tree that includes domestic dogs diverged from that of the gray wolf more than 15,000 years ago. Due to selective breeding by humans throughout history, dogs today exhibit an extremely wide range of body types and behaviors. In fact, dogs exhibit the greatest diversity in body size of any mammalian species.

An international team led by scientists from the U.S. National Human Genome Research Institute (NHGRI; Bethesda, MD, USA), part of the U.S. National Institutes of Health (NIH; Bethesda, MD, USA), identified the genetic variant that is the major contributor to small size in dogs. The findings appear in the April 6, 2007, issue of the journal Science.

The identification and characterization of a key genetic variant that accounts for differences in dog size is particularly exciting because the underlying gene is present in all dogs and other diverse species, including humans, said Eric Green, M.D., Ph.D., scientific director of the NHGRI Division of Intramural Research. Discoveries like this illustrate the exciting promise of genomics research for understanding the inheritance of a wide range of traits, including those that have an impact on health and disease.

We have been intrigued by the population structure of dogs, which over the years have been selectively bred, allowing us to more readily analyze the genetic causes of particular traits than is possible in humans, said the study's senior author, Elaine A. Ostrander, Ph.D., chief of NHGRI's Cancer Genetics Branch. Nearly all of what we learn from studying body structure, behavior, and disease susceptibility in dogs helps us understand some aspect of human health and biology.

The researchers analyzed DNA from more than 3,000 dogs from 143 breeds to pinpoint a specific gene sequence variant, or haplotype, associated with small size in the canine genetic code. Nearly all of the small dogs studied shared this genetic variant, implicating it as a major influence on stature in dogs.

Based on their genomic analysis, the researchers also concluded that the small size trait emerged relatively early in the history of domestic dogs. They hypothesize that small size may have facilitated the rapid diversification among domestic dog breeds by making it easier for humans to maintain them in the crowded confines of developing villages and cities, as well as making them more transportable during trade and migration.

By learning how genes control body size in dogs, we are apt to learn something about how skeletal body size is genetically programmed in humans. We also will increase our data set of genes likely to play a role in diseases such as cancer, in which regulation of cell growth has been lost, said Dr. Ostrander, noting that the role of the IGF-1 gene family in prostate cancer susceptibility has already been well established.


Related Links:
NHGRI
NIH

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Pipette Controller
Sapphire MaxiPette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.